Clinical Trail
Immusoft to Announce Positive Phase 1 Data for First Engineered B Cell Therapy in a Clinical Trial
Immusoft
PR-09-24-NI-11Sep 23, 2024
Appointment
Immusoft Announces the Appointment of Robert Hayes, Ph.D. as Chief Scientific Officer
Immusoft
PR-M07-19-NI-053Jul 22, 2019